Risks and benefits of statins in lupus erythematosus

被引：7
作者：
Noël, B
机构：
来源：
ARCHIVES OF INTERNAL MEDICINE | 2004年 / 164卷 / 01期
关键词：
D O I：
10.1001/archinte.164.1.107-b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：107 / 108
页数：2
相关论文
共 11 条
[1]   LUPUS-LIKE SYNDROME ASSOCIATED WITH SIMVASTATIN [J].
BANNWARTH, B ;
MIREMONT, G ;
PAPAPIETRO, PM .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (05) :1093-1093
[2]  
Bruce IN, 1999, J RHEUMATOL, V26, P2137
[3]   Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis [J].
Graziadei, IW ;
Obermoser, GE ;
Sepp, NT ;
Erhart, KH ;
Vogel, W .
LUPUS, 2003, 12 (05) :409-412
[4]   Lupus-like syndrome associated with simvastatin [J].
Hanson, J ;
Bossingham, D .
LANCET, 1998, 352 (9133) :1070-1070
[5]   Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death [J].
Knapp, AC ;
Huang, JW ;
Starling, G ;
Kiener, PA .
ATHEROSCLEROSIS, 2000, 152 (01) :217-227
[6]   Statins as a newly recognized type of immunomodulator [J].
Kwak, B ;
Mulhaupt, F ;
Myit, S ;
Mach, F .
NATURE MEDICINE, 2000, 6 (12) :1399-1402
[7]   Atorvastatin-induced dermatomyositis [J].
Noël, B ;
Cerottini, JP ;
Panizzon, RG .
AMERICAN JOURNAL OF MEDICINE, 2001, 110 (08) :670-671
[8]   The cardiovascular burden of lupus - A complex challenge [J].
Schattner, A .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (13) :1507-1510
[9]   Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus [J].
Srivastava, M ;
Rencic, A ;
Diglio, G ;
Santana, H ;
Bonitz, P ;
Watson, R ;
Ha, E ;
Anhalt, GJ ;
Provost, TT ;
Nousari, CH .
ARCHIVES OF DERMATOLOGY, 2003, 139 (01) :45-49
[10]  
Stoebner PE, 2003, ANN DERMATOL VENER, V130, P187
12